Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or...
Reexamination Certificate
2005-03-22
2005-03-22
Saucier, Sandra E. (Department: 1651)
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
C435S001200, C435S001300, C435S002000
Reexamination Certificate
active
06869757
ABSTRACT:
Disclosed herein is a carrier solution for cryoprotectants that is useful for use with cells, tissues, and whole organs and for a variety of cryoprotectant solutions and that permits antinucleators to be fully effective in vitrification solutions, thereby allowing vitrification solutions to attain extreme effectiveness, and compatible vitrification solution compositions for use with this carrier solution. The carrier solution comprises lactose and mannitol as well as other beneficial ingredients.
REFERENCES:
patent: 5800978 (1998-09-01), Goodrich, Jr. et al.
patent: 5879875 (1999-03-01), Wiggins et al.
patent: 6194137 (2001-02-01), Khirabadi et al.
patent: 6395467 (2002-05-01), Fahy et al.
patent: 20020045156 (2002-04-01), Toner et al.
patent: 1-106826 (1989-04-01), None
Klebe et al., “Identification of new cryoprotective agents for cultured mammalian cells”, In Vitro 19 (3 part I):167-70.*
Merck Index, entry 56, 1989.*
Williams et al., “Vial Breakage by Frozen Mannitol Solutions: Correlation with Thermal Characteristics and Effect of Stereoisomerism, Addivitves and Vial Configuration”, J. Parenteral Science & Technology 45 (2):94-100 (1991).*
Ren et al., “The Crystallization Kinetics and the Critical Cooling Rates for Vitrification of Cryoprotective Solutions”, Cryogenics 30:536-40 (1990).*
Fahy, Gregory M. and Ali, Suja E., Cryopreservation of the Mammalian Kidney,Cryobiology, 35: 114-1131, 1997.
Kheirabadi. Bijan S. and Fahy, Gregory M., Permanent Life Support By Kidneys Perfused with a Vitrifiable (7.5 Molar) Cryoprotectant Solution,Transplantation, 70: 51-57, 2000.
Khirabadi, Bijan S. and Fahy, Gregory M., Cryopreservation of the Mammalian Kidney—Transplantation of Rabbit Kidneys Perfused with EC and RPS-2 at 2-4° C1,Cryobiology, 31:10-25, 1994.
Kirabadi, B. S., Fahy, G.M., Merei, J., and Rasch, C., Does Substitution of Mannitol for Glucose Improve Euro-Collins as a Vehicle for Cryoprotective Agents?,Cryobiology, 35: 357, 1997.
Arnaud, Francoise, Khirabadi, Bijan S., Fahy, Gregory M., Normothermic blood perfusion of isolated rabbit kidneys,Transpl Int, 15: 278-289, 2002.
Fahy, Gregory M. et al., Cellular Injury Associated with Organ Cryopreservation: Chemical Toxicity and Cooling Injury,Cell Biology of Trauma, CRC Press, Boca Raton, Chapter 20: 333-356, 1995.
Rall, W. F. and Fahy, G. M., Ice-free cryopreservation of mouse embryos at—196° C by vitrification,Nature, 313: 573-575, 1985.
21st Century Medicine, Inc.
Foley & Lardner LLP
Reiter Stephen E.
Saucier Sandra E.
LandOfFree
Advantageous carrier solution for vitrifiable concentrations... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Advantageous carrier solution for vitrifiable concentrations..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Advantageous carrier solution for vitrifiable concentrations... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3398142